GAD THOMAS (President and Chairman) sold 12.2% of their position (32.35K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $395.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/23/2024ACC: 0001104659-24-064808
DirectorOfficer· President and Chairman
Since Sep 2018
-32.35K
Net shares
Net seller
$395.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
32.35K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−25K
Price / share
$12.00
Trade value
$300K
% of position
9.4%
5/21/2024
265.03K→240.03K
Common Stock
Indirect
Shares
−7.35K
Price / share
$13.00
Trade value
$95.56K
% of position
3.1%
5/23/2024
240.03K→232.68K
Total
Net shares
−32.35K
Net value
-$395.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/21/2024 | S · Sale | −25K | $12.00 | $300K | 9.4% | 265.03K | 240.03K |
| Common Stock Indirect | 5/23/2024 | S · Sale | −7.35K | $13.00 | $95.56K | 3.1% | 240.03K | 232.68K |
| Total | −32.35K | -$395.56K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned158.70K
Common Stock
IndirectShares owned60K
Total
158.70K direct·60K indirect218.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 158.70K | Direct |
| Common Stock | 60K | Indirect |
| Total | 218.70K | 158.70K direct·60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported